2l3c
From Proteopedia
(Difference between revisions)
Line 7: | Line 7: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2l3c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l3c OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2l3c RCSB], [http://www.ebi.ac.uk/pdbsum/2l3c PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2l3c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l3c OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2l3c RCSB], [http://www.ebi.ac.uk/pdbsum/2l3c PDBsum]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/RED1_RAT RED1_RAT]] Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing. This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2 and GRIK2) and serotonin (HTR2C), GABA receptor (GABRA3) and potassium voltage-gated channel (KCNA1). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alter their functional activities. Edits GRIA2 at both the Q/R and R/G sites efficiently but converts the adenosine in hotspot1 much less efficiently (By similarity). Can inhibit cell proliferation and migration and can stimulate exocytosis.<ref>PMID:20501795</ref> <ref>PMID:16472753</ref> <ref>PMID:20946981</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 20: | Line 22: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Rattus norvegicus]] | [[Category: Rattus norvegicus]] | ||
- | [[Category: Allain, F | + | [[Category: Allain, F]] |
- | [[Category: Oberstrass, F | + | [[Category: Oberstrass, F]] |
- | [[Category: Stefl, R | + | [[Category: Stefl, R]] |
[[Category: Dsrbm]] | [[Category: Dsrbm]] | ||
[[Category: Dsrna recognition]] | [[Category: Dsrna recognition]] | ||
[[Category: Editing]] | [[Category: Editing]] | ||
[[Category: Hydrolase-rna complex]] | [[Category: Hydrolase-rna complex]] |
Revision as of 23:48, 24 December 2014
Solution structure of ADAR2 dsRBM1 bound to LSL RNA
|